Assess the activity of ABT-737 as a single agent against neuroblastoma cell lines grown in cell culture
|
Children’s Hospital Los Angeles / Theresa Harned, MD |
Young Investigator Grants |
2006 |
California |
Cancer Susceptibility and Signaling Pathways in Low-Grade Brain Tumors |
Jewish General Hospital / Bárbara Rivera, PhD |
Young Investigator Grants |
2017 |
Quebec |
Ca2+ Release Activated Ca2+ (CRAC) Channels in Control of Leukemic Cell Metabolism and Leukemia Stem Cell Maintenance in T-ALL |
New York University School of Medicine / Mate Maus, PhD |
Young Investigator Grants |
2014 |
New York |
Identification and Validation of Differentiation Therapy for Osteosarcoma
|
Dana-Farber Cancer Institute / Katherine Janeway, MD |
Young Investigator Grants |
2008 |
Massachusetts |
Interrogating the Enhancer Landscapes of Ependymoma to Inform Novel Therapies |
Baylor College of Medicine / Stephen Mack, PhD |
Young Investigator Grants |
2016 |
Texas |
CDK8 as a New Therapeutic Target in Alveolar Rhabdomyosarcoma |
Dana-Farber Cancer Institute / Susu Zhang, PhD |
Young Investigator Grants |
2023 |
Massachusetts |
Understanding the Mechanisms of HOX Gene Regulation in Normal and Leukemic Hematopoietic Stem Cells to Identify New Therapies for Pediatric AML |
Boston Children’s Hospital / Anne Robertson, PhD |
Young Investigator Grants |
2017 |
Massachusetts |
A Role for Non-canonical Wnt/PCP Signaling in Growth and Self-Renewal of Embryonal Rhabdomyosarcoma |
Massachusetts General Hospital / Madeline Hayes, PhD |
Young Investigator Grants |
2016 |
Massachusetts |
Using Neurofibromatosis-1 (NF1) to understand Pediatric Brain Tumor Initiation |
MD Anderson Cancer Center / Yuan Pan, PhD |
Young Investigator Grants |
2020 |
Texas |
The Regulation of Hematopoietic Stem Cell Function by Granulocyte-Colony Stimulating Factor |
Washington University / Laura Schuettpelz, MD, PhD |
Young Investigator Grants |
2013 |
Missouri |